NOX 4.00% 7.2¢ noxopharm limited

Ann: LuPIN Survival Outcome Confirmed by Conference Presentation, page-13

  1. 1,026 Posts.
    lightbulb Created with Sketch. 38
    in terms of drug getting Fda approval, it needs to do trials. This study though gives GenisisCare a case to use Veyonda and lu psma on compasionate grounds. I would expect some sort of revenue pickup.
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
7.2¢
Change
-0.003(4.00%)
Mkt cap ! $21.04M
Open High Low Value Volume
7.2¢ 7.2¢ 7.2¢ $934 12.96K

Buyers (Bids)

No. Vol. Price($)
2 67034 7.2¢
 

Sellers (Offers)

Price($) Vol. No.
7.9¢ 12000 1
View Market Depth
Last trade - 11.41am 18/07/2024 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.